Co-creating health for humanity: New trends in interorganizational pharmaceutical deals
It is a challenging feat to launch a new drug in the market, given the low probability of success during the research and development (R&D) phase and the high costs involved. In recent times, industry trends in external innovation ...
Jan 24, 2023
0
3